Emea was Stevanato Group S.p.A’s largest region in fiscal 2025, bringing in $690.34M of $1.19B (58%).
| Geography | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Emea | $599.71M | $634.05M | $667.83M | $690.34M | |||
| North America | $250.84M | $317.54M | $308.95M | $362.06M | |||
| Apac | $100.26M | $102.90M | $96.24M | $101.48M | |||
| Italy | — | $77.84M | $72.07M | — | |||
| South America | $32.87M | $30.87M | $31.02M | $32.40M | |||
| Total | $983.68M | $1.16B | $1.18B | $1.19B |
Stevanato Group S.p.A brought in $1.19B from its four regions in fiscal 2025, the year ended December 31, 2025. Stevanato Group S.p.A regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $1.18B. Emea was the largest at $690.34M (58.2%), ahead of North America at $362.06M (30.5%) and Apac at $101.48M (8.6%). The remaining region, South America, brought in $32.40M.
Compared with fiscal 2024, North America grew fastest, up 17.2% to $362.06M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $983.68M to $1.19B, a compound annual growth rate of 6.4%. Emea's share of the total fell from 61.0% to 58.2%.
Stevanato Group S.p.A stopped reporting Italy as a separate region after fiscal 2024, when it brought in $72.07M.
High-Value Solutions was Stevanato Group S.p.A’s largest revenue line in fiscal 2025, bringing in $546.37M of $1.19B (46%).
| Products and services [axis] | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Other Containment & Delivery Solutions | $506.42M | $512.86M | $511.39M | $491.80M | |||
| High-Value Solutions | $293.23M | $366.43M | $422.35M | $546.37M | |||
| Revenue From Engineering | $184.03M | $206.07M | $170.29M | $148.11M | |||
| Revenues From Engineering | — | — | — | — | |||
| Sale Of Residential Flat | — | — | — | — | |||
| Total | $983.68M | $1.09B | $1.10B | $1.19B |
Stevanato Group S.p.A brought in $1.19B from its three revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 7.4% from $1.10B in fiscal 2024. High-Value Solutions was the largest at $546.37M (46.1%), ahead of Other Containment & Delivery Solutions at $491.80M (41.5%) and Revenue From Engineering at $148.11M (12.5%).
Compared with fiscal 2024, High-Value Solutions grew fastest, up 29.4% to $546.37M, while Revenue From Engineering fell the most, down 13.0% to $148.11M. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $983.68M to $1.19B, a compound annual growth rate of 6.4%. High-Value Solutions' share of the total rose from 29.8% to 46.1%.
Biopharmaceutical & Diagnostic Solutions was Stevanato Group S.p.A’s largest segment in fiscal 2025, bringing in $1.04B of $1.19B (88%).
| Segments [axis] | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Biopharmaceutical & Diagnostic Solutions | $801.24M | $881.34M | $937.78M | $1.04B | |||
| Engineering | $299.50M | $372.81M | $357.64M | $281.01M | |||
| Adjustments, Eliminations & Unallocated Items | -$117.06M | -$168.79M | -$191.38M | -$135.06M | |||
| Total | $983.68M | $1.09B | $1.10B | $1.19B |
Stevanato Group S.p.A brought in $1.19B from its three segments in fiscal 2025, the year ended December 31, 2025. That was up 7.4% from $1.10B in fiscal 2024. Biopharmaceutical & Diagnostic Solutions was the largest at $1.04B (87.7%), ahead of Engineering at $281.01M (23.7%).
Compared with fiscal 2024, Biopharmaceutical & Diagnostic Solutions grew 10.9% to $1.04B, while Engineering fell 21.4% to $281.01M. From fiscal 2022 to 2025, combined revenue from these segments grew from $983.68M to $1.19B, a compound annual growth rate of 6.4%. Biopharmaceutical & Diagnostic Solutions' share of the total rose from 81.5% to 87.7%.
The total is net of Adjustments, Eliminations & Unallocated Items, which took $135.06M off revenue in fiscal 2025.
Stevanato Group S.p.A (STVN) reports its revenue by geography, by products and services [axis] and by segments [axis]. In fiscal 2025, Emea was its largest region, bringing in $690.34M (58.2% of the total), followed by North America at $362.06M (30.5%).
Emea was Stevanato Group S.p.A's largest region in fiscal 2025, bringing in $690.34M, or 58.2% of the $1.19B total across its four regions.
High-Value Solutions was Stevanato Group S.p.A's largest revenue line in fiscal 2025, bringing in $546.37M, or 46.1% of the $1.19B total across its three revenue lines.
Biopharmaceutical & Diagnostic Solutions was Stevanato Group S.p.A's largest segment in fiscal 2025, bringing in $1.04B, or 87.7% of the $1.19B total across its three segments.
Among Stevanato Group S.p.A's revenue lines that make up at least 2% of revenue, High-Value Solutions grew fastest in fiscal 2025, up 29.4% from $422.35M to $546.37M.
Every figure comes from Stevanato Group S.p.A's annual financial filings, as reported. Each line keeps the name Stevanato Group S.p.A gives it, and years follow its fiscal calendar.
Stevanato Group S.p.A's revenue by geography goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.